Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of different treatment regimens of rituximab
(MabThera®/Rituxan®), corticosteroids, and placebo, combined with methotrexate (MTX), in
patients with active rheumatoid arthritis (RA).